Rocket Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Good afternoon. My name is Ankit Agarwal. I'm an associate with the Investment Banking Group at JPMorgan. It's a pleasure to have you all guys here this afternoon.
Our next guest is Mr. Gaurav Shah, CEO and President of Rocket Pharmaceuticals.
Thank you, Ankit. Thank you, JPMorgan. This is the first time that we're presenting and hopefully for many years to come.
So friends, welcome to the 2020s. Like the 1920s, which is when penicillin and insulin made a lot of headway, this decade may be anticipated to be roaring again with regard to curative medical innovations. And I'm super happy that Rocket is a part of the story of this decade.
So 3 key take-homes. There's always 3, right? Despite being a relatively young company, we did a reverse merge 2 years ago. We have largely been under the radar. We do now have 4 gene therapies in the clinic. Two have already achieved proof of concept, but each one of them is first, best and only
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
